Literature DB >> 21465121

Vaccination coverage among adolescents and risk factors associated with incomplete immunization.

Irine-Ikbale Sakou1, Artemis K Tsitsika, Vassiliki Papaevangelou, Eleni C Tzavela, Donald E Greydanus, Maria N Tsolia.   

Abstract

The compliance with vaccination recommendations in adolescence has not been well documented in Greece. The aims of the present study were to estimate the vaccination coverage in a sample of adolescents and to identify risk factors associated with incomplete immunization. Α total of 1,005 adolescents aged 11 to 19 years who were outpatient visitors at an Adolescent Health Unit were included in this study. Participation required parental presence and consent and presentation of the official Child Health Booklet, from which immunizations were transcribed. The highest coverage rates were observed for childhood immunizations: poliomyelitis and hepatitis B (both 96%), measles/mumps/rubella (MMR; 93.1%), and meningitidis C (MenC; 83.4%). By contrast, lower rates were shown for the booster dose of tetanus/diphtheria/pertussis (39.6%), for hepatitis A (HAV; 59.1%), for the varicella vaccine (13.8% among adolescents without disease history), and among girls for the human papillomavirus vaccine (11.9%). We found a significant association between age and series completion for MMR, MenC, and HAV, with lower uptake among older adolescents . Overall, 22.7% of study participants were fully vaccinated according to criteria employed. In particular, non-urban residents, non-nationals, and females had lower likelihood of being fully vaccinated. In conclusion, our findings suggest suboptimal vaccination coverage among our sample's adolescents, mandating that every effort should be made to increase uptake, particularly among the geographically dispersed and the culturally diverse and female adolescents.

Entities:  

Mesh:

Year:  2011        PMID: 21465121     DOI: 10.1007/s00431-011-1456-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Barriers to adolescent immunization: a survey of family physicians and pediatricians.

Authors:  Natalia Vukshich Oster; Carol A McPhillips-Tangum; Francisco Averhoff; Kelly Howell
Journal:  J Am Board Fam Pract       Date:  2005 Jan-Feb

2.  Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles.

Authors:  Nazek Abdelmutti; Laurie Hoffman-Goetz
Journal:  Women Health       Date:  2009 Jul-Aug

3.  Control of hepatitis A through routine vaccination of children.

Authors:  F Averhoff; C N Shapiro; B P Bell; I Hyams; L Burd; A Deladisma; E P Simard; D Nalin; B Kuter; C Ward; M Lundberg; N Smith; H S Margolis
Journal:  JAMA       Date:  2001-12-19       Impact factor: 56.272

4.  Compliance with recommended immunizations in adolescents.

Authors:  Ulrich Heininger; Kerstin Loos; Imke Lorenz; Wolfgang Rascher
Journal:  Eur J Pediatr       Date:  2006-05-18       Impact factor: 3.183

5.  National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines.

Authors:  Cynthia M Rand; Laura P Shone; Christina Albertin; Peggy Auinger; Jonathan D Klein; Peter G Szilagyi
Journal:  Arch Pediatr Adolesc Med       Date:  2007-03

6.  Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Oleg O Bilukha; Nancy Rosenstein
Journal:  MMWR Recomm Rep       Date:  2005-05-27

Review 7.  Epidemiology of pertussis.

Authors:  Tina Tan; Evelinda Trindade; Danuta Skowronski
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

8.  Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Karen R Broder; Margaret M Cortese; John K Iskander; Katrina Kretsinger; Barbara A Slade; Kristin H Brown; Christina M Mijalski; Tejpratap Tiwari; Emily J Weston; Amanda C Cohn; Pamela U Srivastava; John S Moran; Benjamin Schwartz; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-03-24

9.  Varicella vaccination in Europe: are we ready for a universal childhood programme?

Authors:  Nitu Sengupta; Robert Booy; H J Schmitt; Heikki Peltola; Pierre Van-Damme; R Fabian Schumacher; Magda Campins; Carlos Rodrigo; Terho Heikkinen; Jane Seward; Aisha Jumaan; Adam Finn; Per Olcén; Nancy Thiry; Catherine Weil-Olivier; Judith Breuer
Journal:  Eur J Pediatr       Date:  2007-03-03       Impact factor: 3.860

Review 10.  What is new in pertussis?

Authors:  Ellen S Bamberger; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2007-08-01       Impact factor: 3.183

View more
  17 in total

1.  HPV vaccine acceptability in high-risk Greek men.

Authors:  Lea Hoefer; Savas Tsikis; George Bethimoutis; Electra Nicolaidou; Vassilios Paparizos; Christina Antoniou; Antonios Kanelleas; Leonidas Chardalias; Georgios-Emmanouil Stavropoulos; John Schneider; Angella Charnot-Katsikas
Journal:  Hum Vaccin Immunother       Date:  2017-10-24       Impact factor: 3.452

2.  Vaccine coverage in children, adolescents and adults with type 1 diabetes and their close contacts in Crete.

Authors:  Victoria Giatraki; Helen Dimitriou; Aggelos Pappas; Dimitris Mamoulakis; George Makris; Emmanouil Galanakis; Chrysoula Perdikogianni
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

3.  Evaluating the vaccination coverage: validity of household-hold vaccination booklet and caregiver's recall.

Authors:  Yu Hu; Hu Liang; Fuxing Chen; Linzhi Shen; Xuejiao Pan; Ying Wang; Yaping Chen; Huakun Lv
Journal:  Hum Vaccin Immunother       Date:  2021-04-07       Impact factor: 3.452

4.  Pertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980-2008).

Authors:  Maria Theodoridou; Georgia Dargenta; Maria Aptouramani; Panagiotis Papastergiou; Anna Katsiaflaka; Kalliopi Theodoridou; Christos Hadjichristodoulou
Journal:  Adv Prev Med       Date:  2012-09-16

5.  Vaccination coverage among school children in Western Greece from 2016 to 2019.

Authors:  A Kanellopoulou; I Giannakopoulos; S Fouzas; E Papachatzi; S Nasikas; A Papakonstantinopoulou; G Dimitriou; D Gkentzi
Journal:  Hum Vaccin Immunother       Date:  2021-09-02       Impact factor: 4.526

6.  Analysis of the effects of individual- and community- level predictors on migrant children's primary immunization in Yiwu city, east China.

Authors:  Yu Hu; Yaping Chen; Hui Liang; Ying Wang
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 4.526

Review 7.  Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis.

Authors:  Garden Tabacchi; Claudio Costantino; Giuseppe Napoli; Valentina Marchese; Manuela Cracchiolo; Alessandra Casuccio; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2016-05-10       Impact factor: 3.452

8.  Vaccination against human papillomavirus among 865 female students from the health professions in central Greece: a questionnaire-based cross-sectional study.

Authors:  Dimitrios Papagiannis; George Rachiotis; Emmanouil K Symvoulakis; Alexandros Daponte; Ioanna N Grivea; George A Syrogiannopoulos; Christos Hadjichristodoulou
Journal:  J Multidiscip Healthc       Date:  2013-11-28

9.  Greek health professionals' perceptions of the HPV vaccine, state policy recommendations and their own role with regards to communication of relevant health information.

Authors:  Christina Karamanidou; Kostas Dimopoulos
Journal:  BMC Public Health       Date:  2016-06-03       Impact factor: 3.295

10.  Hepatitis B Virus Vaccination Coverage in Medical, Nursing, and Paramedical Students: A Cross-Sectional, Multi-Centered Study in Greece.

Authors:  Dimitrios Papagiannis; Zoi Tsimtsiou; Ioanna Chatzichristodoulou; Maria Adamopoulou; Ilias Kallistratos; Spyros Pournaras; Malamatenia Arvanitidou; George Rachiotis
Journal:  Int J Environ Res Public Health       Date:  2016-03-15       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.